1 Study Coverage 1.1 Super Generic Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Super Generic Drugs Market Size Growth Rate by Type 1.2.2 Traditional Generic Drugs 1.2.3 Biosimilars 1.3 Market by Application 1.3.1 Global Super Generic Drugs Market Size Growth Rate by Application 1.3.2 CNS 1.3.3 Cardiovascular 1.3.4 Genitourinary/Hormonal Drugs 1.3.5 Respiratory 1.3.6 Rheumatology 1.3.7 Diabetes 1.3.8 Oncology 1.3.9 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Super Generic Drugs Market Size, Estimates and Forecasts 2.1.1 Global Super Generic Drugs Revenue 2016-2027 2.1.2 Global Super Generic Drugs Sales 2016-2027 2.2 Global Super Generic Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Super Generic Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Super Generic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Super Generic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Super Generic Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Super Generic Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Super Generic Drugs Revenue Forecast by Region (2022-2027) 3 Global Super Generic Drugs Competitor Landscape by Players 3.1 Global Top Super Generic Drugs Manufacturers by Sales 3.1.1 Global Super Generic Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Super Generic Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Super Generic Drugs Manufacturers by Revenue 3.2.1 Key Super Generic Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Super Generic Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Super Generic Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Super Generic Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Super Generic Drugs Revenue in 2020 3.2.6 Global Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Super Generic Drugs Price by Manufacturers 3.4 Global Super Generic Drugs Manufacturing Base Distribution, Product Types 3.4.1 Super Generic Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Super Generic Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Super Generic Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Super Generic Drugs Market Size by Type (2016-2021) 4.1.1 Global Super Generic Drugs Sales by Type (2016-2021) 4.1.2 Global Super Generic Drugs Revenue by Type (2016-2021) 4.1.3 Super Generic Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Super Generic Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Super Generic Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Super Generic Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Super Generic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Super Generic Drugs Market Size by Application (2016-2021) 5.1.1 Global Super Generic Drugs Sales by Application (2016-2021) 5.1.2 Global Super Generic Drugs Revenue by Application (2016-2021) 5.1.3 Super Generic Drugs Price by Application (2016-2021) 5.2 Super Generic Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Super Generic Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Super Generic Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Super Generic Drugs Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Super Generic Drugs Market Size YoY Growth 2016-2027 6.1.1 Japan Super Generic Drugs Sales YoY Growth 2016-2027 6.1.2 Japan Super Generic Drugs Revenue YoY Growth 2016-2027 6.1.3 Japan Super Generic Drugs Market Share in Global Market 2016-2027 6.2 Japan Super Generic Drugs Market Size by Players (International and Local Players) 6.2.1 Japan Top Super Generic Drugs Players by Sales (2016-2021) 6.2.2 Japan Top Super Generic Drugs Players by Revenue (2016-2021) 6.3 Japan Super Generic Drugs Historic Market Review by Type (2016-2021) 6.3.1 Japan Super Generic Drugs Sales Market Share by Type (2016-2021) 6.3.2 Japan Super Generic Drugs Revenue Market Share by Type (2016-2021) 6.3.3 Japan Super Generic Drugs Price by Type (2016-2021) 6.4 Japan Super Generic Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Super Generic Drugs Sales Forecast by Type (2022-2027) 6.4.2 Japan Super Generic Drugs Revenue Forecast by Type (2022-2027) 6.4.3 Japan Super Generic Drugs Price Forecast by Type (2022-2027) 6.5 Japan Super Generic Drugs Historic Market Review by Application (2016-2021) 6.5.1 Japan Super Generic Drugs Sales Market Share by Application (2016-2021) 6.5.2 Japan Super Generic Drugs Revenue Market Share by Application (2016-2021) 6.5.3 Japan Super Generic Drugs Price by Application (2016-2021) 6.6 Japan Super Generic Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Super Generic Drugs Sales Forecast by Application (2022-2027) 6.6.2 Japan Super Generic Drugs Revenue Forecast by Application (2022-2027) 6.6.3 Japan Super Generic Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Super Generic Drugs Market Size YoY Growth 2016-2027 7.2 North America Super Generic Drugs Market Facts & Figures by Country 7.2.1 North America Super Generic Drugs Sales by Country (2016-2021) 7.2.2 North America Super Generic Drugs Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Super Generic Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Super Generic Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Super Generic Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Super Generic Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Super Generic Drugs Market Size YoY Growth 2016-2027 9.2 Europe Super Generic Drugs Market Facts & Figures by Country 9.2.1 Europe Super Generic Drugs Sales by Country (2016-2021) 9.2.2 Europe Super Generic Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Super Generic Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Super Generic Drugs Market Facts & Figures by Country 10.2.1 Latin America Super Generic Drugs Sales by Country (2016-2021) 10.2.2 Latin America Super Generic Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Super Generic Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Super Generic Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Super Generic Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Super Generic Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Teva 12.1.1 Teva Corporation Information 12.1.2 Teva Description and Business Overview 12.1.3 Teva Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Teva Super Generic Drugs Products Offered 12.1.5 Teva Recent Development 12.2 Novartis - Sandoz 12.2.1 Novartis - Sandoz Corporation Information 12.2.2 Novartis - Sandoz Description and Business Overview 12.2.3 Novartis - Sandoz Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis - Sandoz Super Generic Drugs Products Offered 12.2.5 Novartis - Sandoz Recent Development 12.3 Mylan 12.3.1 Mylan Corporation Information 12.3.2 Mylan Description and Business Overview 12.3.3 Mylan Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Mylan Super Generic Drugs Products Offered 12.3.5 Mylan Recent Development 12.4 Sun Pharmaceutical 12.4.1 Sun Pharmaceutical Corporation Information 12.4.2 Sun Pharmaceutical Description and Business Overview 12.4.3 Sun Pharmaceutical Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sun Pharmaceutical Super Generic Drugs Products Offered 12.4.5 Sun Pharmaceutical Recent Development 12.5 Aspen 12.5.1 Aspen Corporation Information 12.5.2 Aspen Description and Business Overview 12.5.3 Aspen Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Aspen Super Generic Drugs Products Offered 12.5.5 Aspen Recent Development 12.6 Fresenius Kabi 12.6.1 Fresenius Kabi Corporation Information 12.6.2 Fresenius Kabi Description and Business Overview 12.6.3 Fresenius Kabi Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Fresenius Kabi Super Generic Drugs Products Offered 12.6.5 Fresenius Kabi Recent Development 12.7 Pfizer (Hospira) 12.7.1 Pfizer (Hospira) Corporation Information 12.7.2 Pfizer (Hospira) Description and Business Overview 12.7.3 Pfizer (Hospira) Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Pfizer (Hospira) Super Generic Drugs Products Offered 12.7.5 Pfizer (Hospira) Recent Development 12.8 Sanofi 12.8.1 Sanofi Corporation Information 12.8.2 Sanofi Description and Business Overview 12.8.3 Sanofi Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Sanofi Super Generic Drugs Products Offered 12.8.5 Sanofi Recent Development 12.9 Aurobindo 12.9.1 Aurobindo Corporation Information 12.9.2 Aurobindo Description and Business Overview 12.9.3 Aurobindo Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Aurobindo Super Generic Drugs Products Offered 12.9.5 Aurobindo Recent Development 12.10 Lupin 12.10.1 Lupin Corporation Information 12.10.2 Lupin Description and Business Overview 12.10.3 Lupin Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Lupin Super Generic Drugs Products Offered 12.10.5 Lupin Recent Development 12.11 Teva 12.11.1 Teva Corporation Information 12.11.2 Teva Description and Business Overview 12.11.3 Teva Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Teva Super Generic Drugs Products Offered 12.11.5 Teva Recent Development 12.12 Apotex 12.12.1 Apotex Corporation Information 12.12.2 Apotex Description and Business Overview 12.12.3 Apotex Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Apotex Products Offered 12.12.5 Apotex Recent Development 12.13 Cipla 12.13.1 Cipla Corporation Information 12.13.2 Cipla Description and Business Overview 12.13.3 Cipla Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Cipla Products Offered 12.13.5 Cipla Recent Development 12.14 ENDO (Par Pharmaceutical) 12.14.1 ENDO (Par Pharmaceutical) Corporation Information 12.14.2 ENDO (Par Pharmaceutical) Description and Business Overview 12.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.14.4 ENDO (Par Pharmaceutical) Products Offered 12.14.5 ENDO (Par Pharmaceutical) Recent Development 12.15 Stada Arzneimittel 12.15.1 Stada Arzneimittel Corporation Information 12.15.2 Stada Arzneimittel Description and Business Overview 12.15.3 Stada Arzneimittel Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Stada Arzneimittel Products Offered 12.15.5 Stada Arzneimittel Recent Development 12.16 Krka Group 12.16.1 Krka Group Corporation Information 12.16.2 Krka Group Description and Business Overview 12.16.3 Krka Group Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Krka Group Products Offered 12.16.5 Krka Group Recent Development 12.17 Nichi-Iko Pharmaceutical 12.17.1 Nichi-Iko Pharmaceutical Corporation Information 12.17.2 Nichi-Iko Pharmaceutical Description and Business Overview 12.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Nichi-Iko Pharmaceutical Products Offered 12.17.5 Nichi-Iko Pharmaceutical Recent Development 12.18 Valeant 12.18.1 Valeant Corporation Information 12.18.2 Valeant Description and Business Overview 12.18.3 Valeant Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Valeant Products Offered 12.18.5 Valeant Recent Development 12.19 Zydus Cadila 12.19.1 Zydus Cadila Corporation Information 12.19.2 Zydus Cadila Description and Business Overview 12.19.3 Zydus Cadila Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Zydus Cadila Products Offered 12.19.5 Zydus Cadila Recent Development 12.20 Hikma 12.20.1 Hikma Corporation Information 12.20.2 Hikma Description and Business Overview 12.20.3 Hikma Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Hikma Products Offered 12.20.5 Hikma Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Super Generic Drugs Industry Trends 13.2 Super Generic Drugs Market Drivers 13.3 Super Generic Drugs Market Challenges 13.4 Super Generic Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Super Generic Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Super Generic Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Traditional Generic Drugs Table 3. Major Manufacturers of Biosimilars Table 4. Global Super Generic Drugs Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Super Generic Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Super Generic Drugs Sales by Regions (2016-2021) & (K Units) Table 7. Global Super Generic Drugs Sales Market Share by Regions (2016-2021) Table 8. Global Super Generic Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Super Generic Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Super Generic Drugs Sales Market Share Forecast by Region (2022-2027) Table 11. Global Super Generic Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Super Generic Drugs Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Super Generic Drugs Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Super Generic Drugs Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Super Generic Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 16. Super Generic Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Super Generic Drugs Revenue Share by Manufacturers (2016-2021) Table 18. Global Super Generic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Super Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Super Generic Drugs as of 2020) Table 20. Key Manufacturers Super Generic Drugs Price (2016-2021) (US$/Unit) Table 21. Super Generic Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Super Generic Drugs Product Type Table 23. Date of International Manufacturers Enter into Super Generic Drugs Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Super Generic Drugs Sales by Type (2016-2021) (K Units) Table 26. Global Super Generic Drugs Sales Share by Type (2016-2021) Table 27. Global Super Generic Drugs Revenue by Type (2016-2021) (US$ Million) Table 28. Global Super Generic Drugs Revenue Share by Type (2016-2021) Table 29. Super Generic Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Super Generic Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Super Generic Drugs Sales Market Share Forecast by Type (2022-2027) Table 32. Global Super Generic Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Super Generic Drugs Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Super Generic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Super Generic Drugs Sales by Application (2016-2021) (K Units) Table 36. Global Super Generic Drugs Sales Share by Application (2016-2021) Table 37. Global Super Generic Drugs Revenue by Application (2016-2021) (US$ Million) Table 38. Global Super Generic Drugs Revenue Share by Application (2016-2021) Table 39. Super Generic Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Super Generic Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Super Generic Drugs Sales Market Share Forecast by Application (2022-2027) Table 42. Global Super Generic Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Super Generic Drugs Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Super Generic Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. Japan Super Generic Drugs Sales (K Units) of Key Companies (2016-2021) Table 46. Japan Super Generic Drugs Sales Share by Company (2016-2021) Table 47. Japan Super Generic Drugs Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Super Generic Drugs Revenue Share by Company (2016-2021) Table 49. Japan Super Generic Drugs Sales (K Units) by Type (2016-2021) Table 50. Japan Super Generic Drugs Sales Share by Type (2016-2021) Table 51. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Super Generic Drugs Price (US$/Unit) by Type (2016-2021) Table 53. Japan Super Generic Drugs Sales (K Units) by Type (2022-2027) Table 54. Japan Super Generic Drugs Sales Share by Type (2022-2027) Table 55. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Super Generic Drugs Revenue Share by Type (2022-2027) Table 57. Japan Super Generic Drugs Price (US$/Unit) by Type (2022-2027) Table 58. Japan Super Generic Drugs Sales (K Units) by Application (2016-2021) Table 59. Japan Super Generic Drugs Sales Share by Application (2016-2021) Table 60. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Super Generic Drugs Price (US$/Unit) by Application (2016-2021) Table 62. Japan Super Generic Drugs Sales (K Units) by Application (2022-2027) Table 63. Japan Super Generic Drugs Sales Share by Application (2022-2027) Table 64. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Super Generic Drugs Revenue Share by Application (2022-2027) Table 66. Japan Super Generic Drugs Price (US$/Unit) by Application (2022-2027) Table 67. North America Super Generic Drugs Sales by Country (2016-2021) & (K Units) Table 68. North America Super Generic Drugs Sales Market Share by Country (2016-2021) Table 69. North America Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Super Generic Drugs Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Super Generic Drugs Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Super Generic Drugs Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Super Generic Drugs Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Super Generic Drugs Revenue Market Share by Region (2016-2021) Table 75. Europe Super Generic Drugs Sales by Country (2016-2021) & (K Units) Table 76. Europe Super Generic Drugs Sales Market Share by Country (2016-2021) Table 77. Europe Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Super Generic Drugs Revenue Market Share by Country (2016-2021) Table 79. Latin America Super Generic Drugs Sales by Country (2016-2021) & (K Units) Table 80. Latin America Super Generic Drugs Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Super Generic Drugs Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Super Generic Drugs Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Super Generic Drugs Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Super Generic Drugs Revenue Market Share by Country (2016-2021) Table 87. Teva Corporation Information Table 88. Teva Description and Business Overview Table 89. Teva Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. Teva Super Generic Drugs Product Table 91. Teva Recent Development Table 92. Novartis - Sandoz Corporation Information Table 93. Novartis - Sandoz Description and Business Overview Table 94. Novartis - Sandoz Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Novartis - Sandoz Product Table 96. Novartis - Sandoz Recent Development Table 97. Mylan Corporation Information Table 98. Mylan Description and Business Overview Table 99. Mylan Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Mylan Product Table 101. Mylan Recent Development Table 102. Sun Pharmaceutical Corporation Information Table 103. Sun Pharmaceutical Description and Business Overview Table 104. Sun Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. Sun Pharmaceutical Product Table 106. Sun Pharmaceutical Recent Development Table 107. Aspen Corporation Information Table 108. Aspen Description and Business Overview Table 109. Aspen Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. Aspen Product Table 111. Aspen Recent Development Table 112. Fresenius Kabi Corporation Information Table 113. Fresenius Kabi Description and Business Overview Table 114. Fresenius Kabi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Fresenius Kabi Product Table 116. Fresenius Kabi Recent Development Table 117. Pfizer (Hospira) Corporation Information Table 118. Pfizer (Hospira) Description and Business Overview Table 119. Pfizer (Hospira) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Pfizer (Hospira) Product Table 121. Pfizer (Hospira) Recent Development Table 122. Sanofi Corporation Information Table 123. Sanofi Description and Business Overview Table 124. Sanofi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Sanofi Product Table 126. Sanofi Recent Development Table 127. Aurobindo Corporation Information Table 128. Aurobindo Description and Business Overview Table 129. Aurobindo Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Aurobindo Product Table 131. Aurobindo Recent Development Table 132. Lupin Corporation Information Table 133. Lupin Description and Business Overview Table 134. Lupin Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Lupin Product Table 136. Lupin Recent Development Table 137. Dr. Reddy's Corporation Information Table 138. Dr. Reddy's Description and Business Overview Table 139. Dr. Reddy's Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. Dr. Reddy's Product Table 141. Dr. Reddy's Recent Development Table 142. Apotex Corporation Information Table 143. Apotex Description and Business Overview Table 144. Apotex Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. Apotex Product Table 146. Apotex Recent Development Table 147. Cipla Corporation Information Table 148. Cipla Description and Business Overview Table 149. Cipla Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Cipla Product Table 151. Cipla Recent Development Table 152. ENDO (Par Pharmaceutical) Corporation Information Table 153. ENDO (Par Pharmaceutical) Description and Business Overview Table 154. ENDO (Par Pharmaceutical) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. ENDO (Par Pharmaceutical) Product Table 156. ENDO (Par Pharmaceutical) Recent Development Table 157. Stada Arzneimittel Corporation Information Table 158. Stada Arzneimittel Description and Business Overview Table 159. Stada Arzneimittel Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Stada Arzneimittel Product Table 161. Stada Arzneimittel Recent Development Table 162. Krka Group Corporation Information Table 163. Krka Group Description and Business Overview Table 164. Krka Group Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. Krka Group Product Table 166. Krka Group Recent Development Table 167. Nichi-Iko Pharmaceutical Corporation Information Table 168. Nichi-Iko Pharmaceutical Description and Business Overview Table 169. Nichi-Iko Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 170. Nichi-Iko Pharmaceutical Product Table 171. Nichi-Iko Pharmaceutical Recent Development Table 172. Valeant Corporation Information Table 173. Valeant Description and Business Overview Table 174. Valeant Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 175. Valeant Product Table 176. Valeant Recent Development Table 177. Zydus Cadila Corporation Information Table 178. Zydus Cadila Description and Business Overview Table 179. Zydus Cadila Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 180. Zydus Cadila Product Table 181. Zydus Cadila Recent Development Table 182. Hikma Corporation Information Table 183. Hikma Description and Business Overview Table 184. Hikma Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 185. Hikma Product Table 186. Hikma Recent Development Table 187. Super Generic Drugs Market Trends Table 188. Super Generic Drugs Market Drivers Table 189. Super Generic Drugs Market Challenges Table 190. Super Generic Drugs Market Restraints Table 191. Super Generic Drugs Customers List Table 192. Super Generic Drugs Distributors List Table 193. Research Programs/Design for This Report Table 194. Key Data Information from Secondary Sources Table 195. Key Data Information from Primary Sources List of Figures Figure 1. Super Generic Drugs Product Picture Figure 2. Global Super Generic Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. Traditional Generic Drugs Product Picture Figure 4. Biosimilars Product Picture Figure 5. Global Super Generic Drugs Sales Market Share by Application in 2020 & 2027 Figure 6. CNS Figure 7. Cardiovascular Figure 8. Genitourinary/Hormonal Drugs Figure 9. Respiratory Figure 10. Rheumatology Figure 11. Diabetes Figure 12. Oncology Figure 13. Others Figure 14. Super Generic Drugs Report Years Considered Figure 15. Global Super Generic Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Super Generic Drugs Market Size 2016-2027 (US$ Million) Figure 17. Global Super Generic Drugs Sales 2016-2027 (K Units) Figure 18. Global Super Generic Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 19. Global Super Generic Drugs Sales Market Share by Region (2016-2021) Figure 20. Global Super Generic Drugs Sales Market Share by Region in 2020 Figure 21. Global Super Generic Drugs Revenue Market Share by Region (2016-2021) Figure 22. Global Super Generic Drugs Revenue Market Share by Region in 2020 Figure 23. Global Super Generic Drugs Sales Share by Manufacturer in 2020 Figure 24. The Top 10 and 5 Players Market Share by Super Generic Drugs Revenue in 2020 Figure 25. Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 26. Global Super Generic Drugs Sales Market Share by Type (2016-2021) Figure 27. Global Super Generic Drugs Sales Market Share by Type in 2020 Figure 28. Global Super Generic Drugs Revenue Market Share by Type (2016-2021) Figure 29. Global Super Generic Drugs Revenue Market Share by Type in 2020 Figure 30. Global Super Generic Drugs Sales Market Share by Application (2016-2021) Figure 31. Global Super Generic Drugs Sales Market Share by Application in 2020 Figure 32. Global Super Generic Drugs Revenue Market Share by Application (2016-2021) Figure 33. Global Super Generic Drugs Revenue Market Share by Application in 2020 Figure 34. Japan Super Generic Drugs Sales Growth Rate 2016-2027 (K Units) Figure 35. Japan Super Generic Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 36. Japan Super Generic Drugs Market Share in Global Market 2016-2027 Figure 37. Japan 5 and 10 Largest Super Generic Drugs Players Market Share by Revenue in Super Generic Drugs in 2020 Figure 38. Japan Super Generic Drugs Revenue Share by Type (2016-2021) Figure 39. Japan Super Generic Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 40. Japan Super Generic Drugs Revenue Share by Application (2016-2021) Figure 41. Japan Super Generic Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 42. North America Super Generic Drugs Sales Growth Rate 2016-2021 (K Units) Figure 43. North America Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 44. North America Super Generic Drugs Sales Market Share by Country in 2020 Figure 45. North America Super Generic Drugs Revenue Market Share by Country in 2020 Figure 46. United States Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 47. United States Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Canada Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 49. Canada Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Europe Super Generic Drugs Sales Growth Rate 2016-2021 (K Units) Figure 51. Europe Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 52. Europe Super Generic Drugs Sales Market Share by Country in 2020 Figure 53. Europe Super Generic Drugs Revenue Market Share by Country in 2020 Figure 54. Germany Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 55. Germany Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. France Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 57. France Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. U.K. Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 59. U.K. Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Italy Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 61. Italy Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Russia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 63. Russia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Asia Pacific Super Generic Drugs Sales Growth Rate 2016-2021 (K Units) Figure 65. Asia Pacific Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 66. Asia Pacific Super Generic Drugs Sales Market Share by Region in 2020 Figure 67. Asia Pacific Super Generic Drugs Revenue Market Share by Region in 2020 Figure 68. China Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 69. China Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Japan Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 71. Japan Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. South Korea Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 73. South Korea Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. India Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 75. India Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Australia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 77. Australia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. China Taiwan Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 79. China Taiwan Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Indonesia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 81. Indonesia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Thailand Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 83. Thailand Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Malaysia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 85. Malaysia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Super Generic Drugs Sales Growth Rate 2016-2021 (K Units) Figure 87. Latin America Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Super Generic Drugs Sales Market Share by Country in 2020 Figure 89. Latin America Super Generic Drugs Revenue Market Share by Country in 2020 Figure 90. Mexico Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 91. Mexico Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 93. Brazil Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 95. Argentina Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Super Generic Drugs Sales Growth Rate 2016-2021 (K Units) Figure 97. Middle East and Africa Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Super Generic Drugs Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Super Generic Drugs Revenue Market Share by Country in 2020 Figure 100. Turkey Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 101. Turkey Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 103. Saudi Arabia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Super Generic Drugs Sales Growth Rate (2016-2021) (K Units) Figure 105. UAE Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Super Generic Drugs Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Teva Novartis - Sandoz Mylan Sun Pharmaceutical Aspen Fresenius Kabi Pfizer (Hospira) Sanofi Aurobindo Lupin Dr. Reddy's Apotex Cipla ENDO (Par Pharmaceutical) Stada Arzneimittel Krka Group Nichi-Iko Pharmaceutical Valeant Zydus Cadila Hikma